Immunovant is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseas ... es. Our singular focus is on the neonatal Fc receptor (FcRn), a novel approach for the treatment of autoimmune diseases caused by pathogenic immunoglobin G (IgG) antibodies. Our investigational compound, IMVT-1401, is a fully human, monoclonal antibody targeting FcRn. It is designed to block FcRn and reduce the amount of disease-causing IgG antibodies circulating in the blood. We are scientists, clinicians, biopharma veterans, and entrepreneurs. We operate with a sense of urgency and encourage out-of-the-box thinking so that our efforts may better help and support people with autoimmune diseases more quickly. Above all, we are passionate about creating value and believe that our collective voices bring new, powerful ideas to life. To learn more about us and our science, visit: https://immunovant.com This is an exciting time to be at Immunovant, and we have key roles open on our career site https://immunovant.com/join-us/ read more